Top stories from April
Tariffs on Canadian drugs could strain US supply chain
Trump to impose tariffs on imported pharmaceuticals
ACA case could affect preventive care for millions
Survey: 35% of US adults cannot afford health care
Tariffs on Chinese goods challenge hospitals
Top trend
Key force shaping the industry with implications and context
Health care affordability. The potential effects of looming tariffs come at a time when more Americans are struggling to afford quality health care and prescription drugs. Hospitals could be facing higher costs and supply chain crunches due to tariffs on imported supplies. This may lead to higher costs for patients, along with reduced services. Hospitals also might curtail investment, particularly in tech. Drug supplies and supply chains may also be negatively affected by the tariffs. And, although some drugmakers are starting to make production investments stateside, generic drugmakers operate on narrow margins and could see some negative effects.
Additional trends
Affordable Care Act uncertainty. Although the Supreme Court appears likely to uphold the preventive care mandate, changes that the Trump administration has proposed to the marketplace could disrupt coverage and make it more expensive for millions of people.
